Effect of botulinum toxin on Raynaud's phenomenon in patients with systemic sclerosis

Not Applicable

• Conditions: Raynaud' s phenomenon

• Registration Number: JPRN-UMIN000019985
• Lead Sponsor: Gunma University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-12-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

Patients under the age 18, with the pregnancy or having the past medical histories with BTX were excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The change in severity of RP, including the frequency, pain, color and duration, by the Raynaud score and VAS at 4 weeks after treatment compared with the baseline.